Privateer Holdings
VC Fund
Seattle, United States
Privateer Holdings is a VC fund in Seattle focused on Medical and Cannabis. Privateer is a private equity firm shaping the future of legal cannabis. Privateer Holdings represents a group of investors from around the world seeking to end cannabis prohibition and the social harms it causes.Through a combination of acquisitions, investments and incubation, Privateer is focused on building a portfolio of global brands thatwill lead, legitimize and define the future of cannabis.The current portfolio includes: Leafly, the world's cannabis information resource; Tilray, a leading global producer of medical cannabis; and Marley Natural, the official cannabis and lifestyle brand of Bob Marley.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
- Fund size:
- $19M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Privateer Holdings invests in
Stages Privateer Holdings invests in
Countries Privateer Holdings invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Medical 1 (50%)
- Cannabis 1 (50%)
- Hospital 1 (50%)
- Software 1 (50%)
- Biopharma 1 (50%)
Stage
- Pre-Seed 1 (50%)
- Series A 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Catherine Jacobson
Director, Clinical Trials
|
Director, Clinical Trials | Total investments: 0 | Find email | |
Christian Groh
Partner
|
Partner | Total investments: 0 | Find email | |
Michael Blue
Managing Partner
|
Managing Partner | Total investments: 0 | Find email | |
Shawn Carpenter
Series B Investor
|
Series B Investor | Total investments: 19 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Bioeureka is a company that has developed image recognition technology powered by artificial intelligence to analyze, interpret and catalog images from a microscope. | $148.3K / Pre-Seed / Jan 04, 2023 | ||
| Tilray is a cannabis-lifestyle and consumer packaged goods company that offers cannabis, hemp-based foods, and craft beverages. Tilray provides pharmaceutical-grade cannabis products to patients, researchers, pharmacies, and governments, they cultivate and deliver the benefits of medical cannabis safely and reliably. Healthcare practitioners andpatients expect and deserve only the best service and products. | $47.7M / Series A / Feb 07, 2018 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Privateer Holdings invest in?
Privateer Holdings invests primarily in Medical, Cannabis and Hospital startups, most often at Pre-Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Privateer Holdings?
Public channels for Privateer Holdings include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Privateer Holdings?
The team at Privateer Holdings includes Catherine Jacobson (Director, Clinical Trials), Christian Groh (Partner) and Michael Blue (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
